Epigallocatechin-3-gallate (EGCG) may inhibit NLRP3 inflammasome activation by clearing mtROS and ox-mtDNA, thereby protecting against lung injury caused by acute pancreatitis (112). This evidence concerns the gene NLRP3 and acute pancreatitis.